Home

International Advocacy

2013 Policy Principles to Promote Biotechnology

Biotechnology helps societies solve old problems in new ways. Through the science of using living cells and the discovery of new molecules, biotech innovation provides societies with innovative means to address their most urgent needs: fighting disease, feeding the hungry, and improving the environment.

Biotech in China

The biosimilars pathway is critical for China's biotechnology industry – and this is evident in the investment the government is making in the manufacture of biotech products

Biotech in the Middle Kingdom Highlights Rules of Engagement in China

For companies looking to partner in China, they must first realize the unique needs of this market.

Podcast: Scientific American Worldview Report and Scorecard Preview, Part One

In this two part series, Scientific American’s Jeremy Abbate talks to editors Mike May and Yali Friedman about the Worldview Report and Scorecard, which will be released at the upcoming BIO International Convention in Boston at a Super Session on June 19.

Podcast: Scientific American Worldview Report and Scorecard Preview, Part Two

In this two part series, Scientific American’s Jeremy Abbate talks to editors Mike May and Yali Friedman about the Worldview Report and Scorecard, which will be released at the upcoming BIO International Convention in Boston at a Super Session on June 19.

BIO and BVGH on Global Health

BIO's President and CEO Jim Greenwood talks to BIO Ventures for Global Health (BVGH) CEO Don Joseph about global health and BVGH's new report on global health.

BIO Media Briefing Highlights 2012 Policy Priorities

BIO President & CEO Jim Greenwood and Tom Watkins, President & CEO of Human Genome Sciences and Chair of BIO’s Board of Directors, recently hosted a media briefing to recap our advocacy accomplishments in 2011 and lay out BIO’s policy priorities for 2012.

The Future of Biotechnology in Japan

What does the future hold for the biotechnology industry in Japan? The Japanese government has made great strides to boost biotech within its borders.

60 Pavilions Showcase Countries, Regions and States at the 2012 BIO International Convention

Pavilions attract attendees and media alike, affording a space to tell your story within the context of a particular geographic region or specific focus area.

China: The Intersection of Innovation

In this informative editorial Jim Greenwood, BIO President and CEO, presents an insight into China’s growing role in the future of biotechnology.

BIO China Brings Together East and West for Partnering and Deal Making

This week’s BIO China International Conference displayed a growing recognition of China’s emergence as a global leader in the biotech industry and discussions focused on how to navigate the opportunities and challenges that exist in the rapidly emerging market.

BIO India Shines the Global Spotlight on Biotech in India

The buzz at BIO India hones in on the lack of clarity and consistency within the clinical trials process

BIO Returns to India and the Industry Continues to Grow

During this period of tremendous growth in both the Indian economy and its healthcare sector, it is a critical time to capitalize on the biotech opportunities available within India.

BIO China: Eastern Biotech Meets Western Biotech

With more than one-fifth of the world’s population, China is an important market for biotech products and is increasingly a key global player in biotech research, development and manufacturing.

Melinda Moree, CEO of BIO Ventures for Global Health

Moree discusses the Forum and the importance of partnering to improving the health of people in developing countries.

Letters, Testimony & Comments

BIO Comments on Colombia Biologics and Biosimilars Regulations
February 22 2013
BIO commends the government of Colombia for taking steps towards developing regulatory requirements for the registry of medicines of...
2013 Special 301 Submission: BIO Provides Input on Biotech IP Challenges Around the Globe
February 8 2013
Biotechnology companies provide unique benefits to the United States and the world. In the health care sector alone, the industry has...
BIO Comments on INPI Guidelines for Examination of Patent Applications
February 1 2013
BIO commends the INPI for their efforts to devise guidelines for examining biotechnology related inventions. Given the technological...
BIO Comments on ANVISA Public Consultation N°66/2012
February 1 2013
BIO respectfully submits both questions and comments for the National Health Surveillance Agency’s (ANVISA) consideration on the...
BIO Comments on India Guidelines for Examining Biotechnology Applications
January 18 2013
Given the importance of protections for basic biotechnology inventions to the survival of the biotechnology sector in India, BIO has...
More Letters, Testimony & Comments →

Press Releases

IFPMA, BIO and WADA Advance Anti-Doping Collaboration with the Launch of 2 Fields 1 Goal Campaign
July 23 2012
Groups Issue Booklet to Help Biotechnology and Pharmaceutical Companies Identify Pipeline Medicines with Doping...
Scientific American to Host BIO International Convention Super Session to Release 4th Annual Worldview Report and Scorecard Highlighting Emerging Markets
June 6 2012
Washington, DC and New York, NY, Wednesday, June 6, 2012 -The 4th Annual Scientific American Worldview Report and...
Orphan Diseases and the Future of BioPharma, the Focus of the 2012 Orphan Disease Forum
April 5 2012
WASHINGTON, D.C.(April 5, 2012)— Thought leaders from dozens of biotech and pharmaceutical corporations from...
BIO Encourages Swift Enactment of Korea-U.S. Free Trade Agreement
October 5 2011
Washington, D.C. (October 5, 2011) – The Biotechnology Industry Organization (BIO) welcomed the transmission of...
Civilian and Military Aviation Biofuels: Companies to Highlight New Technologies and Markets at BIO’s World Congress on Industrial Biotechnology
April 28 2011
WASHINGTON, D.C. (Thursday, April 28, 2011) - Biofuel research and development companies will present progress in...
More Press Releases →